MX9603316A - (+)-liarozol enantiomericamente puro. - Google Patents

(+)-liarozol enantiomericamente puro.

Info

Publication number
MX9603316A
MX9603316A MX9603316A MX9603316A MX9603316A MX 9603316 A MX9603316 A MX 9603316A MX 9603316 A MX9603316 A MX 9603316A MX 9603316 A MX9603316 A MX 9603316A MX 9603316 A MX9603316 A MX 9603316A
Authority
MX
Mexico
Prior art keywords
compounds
liarozole
enantiomerically pure
dextrorotatory isomer
novel
Prior art date
Application number
MX9603316A
Other languages
English (en)
Spanish (es)
Inventor
Marc Gaston Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9603316A publication Critical patent/MX9603316A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9603316A 1994-02-18 1995-02-10 (+)-liarozol enantiomericamente puro. MX9603316A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94200420 1994-02-18
PCT/EP1995/000490 WO1995022540A1 (en) 1994-02-18 1995-02-10 Enantiomerically pure (+)-liarozole

Publications (1)

Publication Number Publication Date
MX9603316A true MX9603316A (es) 1997-02-28

Family

ID=8216652

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603316A MX9603316A (es) 1994-02-18 1995-02-10 (+)-liarozol enantiomericamente puro.

Country Status (12)

Country Link
EP (1) EP0745077A1 (de)
JP (1) JPH09508914A (de)
CN (1) CN1141042A (de)
AU (1) AU689206B2 (de)
CA (1) CA2182583A1 (de)
IL (1) IL112688A0 (de)
MX (1) MX9603316A (de)
NZ (1) NZ279227A (de)
SG (1) SG52325A1 (de)
TW (1) TW401415B (de)
WO (1) WO1995022540A1 (de)
ZA (1) ZA951343B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0800391A1 (de) * 1994-12-28 1997-10-15 Janssen Pharmaceutica N.V. Benzimidazole zur hemmung des calcitriol-metabolismus
EP1992228A1 (de) * 2007-05-14 2008-11-19 Bayer CropScience AG Insektizide substituierte Thiourea-Derivate
US9138393B2 (en) * 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) * 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders

Also Published As

Publication number Publication date
IL112688A0 (en) 1995-05-26
ZA951343B (en) 1996-08-19
TW401415B (en) 2000-08-11
AU689206B2 (en) 1998-03-26
WO1995022540A1 (en) 1995-08-24
CA2182583A1 (en) 1995-08-24
EP0745077A1 (de) 1996-12-04
CN1141042A (zh) 1997-01-22
JPH09508914A (ja) 1997-09-09
NZ279227A (en) 1997-11-24
SG52325A1 (en) 1998-09-28
AU1578795A (en) 1995-09-04

Similar Documents

Publication Publication Date Title
EA200201277A1 (ru) Замещенные бициклические производные для лечения аномального роста клеток
HUT70499A (en) Fluoroalkoxybenzaldehyde derivatives and process for producing them
EA200200509A1 (ru) Новые производные бензоимидазола, используемые в качестве антипролиферативного средства
GR3036816T3 (en) Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
DK0726892T3 (da) (E)-20(22)-dehydrovitamin D-forbindelser
MXPA05006420A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal.
EA200100135A1 (ru) Алкинилзамещенные производные хинолин-2-она, полезные в качестве противораковых агентов
ZA975439B (en) New pyridyl alkane acid amides.
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
EP0807633A3 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
TR200000673T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
TR200000670T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
TW200502221A (en) Novel lactams and uses thereof
HK114895A (en) Use of benzimidazoles in the treatment of epithelial disorders
NZ512526A (en) 4-sulfonamido-6-sulfamidoalkoxypyrimidine derivatives, pharmaceuticals thereof, and their use for the treatment of disorders associated with a role of endothelin.
BG100661A (en) Aryl acetic acid derivatives
PL336640A1 (en) Substituted 3,3-diamino-2- propenonitriles, their production and application
CA2314154A1 (en) Azepine or larger medium ring derivatives and their use as pharmaceuticals
MX9603316A (es) (+)-liarozol enantiomericamente puro.
IL166103A0 (en) Pyrrolidine derivatives and their use
MX9603510A (es) (-)-liarozol enantiomericamente puro.
MX9704704A (es) Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su obtencion, medicamentos que contienen estos compuestos, y su utilizacion.
TNSN86165A1 (fr) Nouveaux ortho-anisamides, leur procede d'obtention et leurs applications therapeutiques
CA2208032A1 (en) Substituted amidinonaphthyl ester derivative
IL115004A0 (en) Use of substituted 6-amino-4h-pyrans as medicaments, certain novel such compounds and their preparation